Search for Clinical Trial Results

Porphyria Cutanea Tarda - 25 Studies Found
Status | Study |
Completed |
Study Name: Risk Factors of Porphyria Cutanea Tarda (PCT) Condition: Porphyria Cutanea Tarda Date: 2005-09-13 |
Completed |
Study Name: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2008-01-10 Interventions: Drug: Deferasirox 250 mg of deferasirox once daily for 6 months |
Recruiting |
Study Name: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2012-04-05 Interventions:
|
Recruiting |
Study Name: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2011-01-26 Interventions: Drug: Exjade Orodispersible Tablet, 10 mg/Kg/day ± 5 mg/Kg/day during 24 weeks Deferasirox should b |
Completed |
Study Name: Study of the Pathogenesis of Porphyria Cutanea Tarda Condition: Porphyria Cutanea Tarda Date: 2000-04-06 |
Not yet recruiting |
Study Name: Harvoni Treatment Porphyria Cutanea Tarda Condition:
Date: 2017-04-13 Interventions: Drug: Harvoni One capsule of Harvoni/ ledipasvir, 90 mg + sofosbuvir, 400 mg administered daily for 8, 1 |
Active, not recruiting |
Study Name: EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) Condition: Acute Hepatic Porphyria Date: 2014-09-11 |
Recruiting |
Study Name: Oral Iron for Erythropoietic Protoporphyrias Condition:
|
Recruiting |
Study Name: Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact Condition:
|
Recruiting |
Study Name: Phase III Confirmatory Study in Erythropoietic Protoporphyria Condition: Erythropoietic Protoporphyria Date: 2012-05-22 Interventions:
|